Second look for ovarian cancer: Laparoscopy or laparotomy? A prospective comparative study

被引:26
作者
Clough, KB
Ladonne, JM
Nos, C
Renolleau, C
Validire, P
Durand, JC
机构
[1] Inst Curie, Dept Surg, F-75005 Paris, France
[2] Inst Curie, Dept Pathol, F-75005 Paris, France
关键词
D O I
10.1006/gyno.1998.5272
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Objective. The objective of this study was to evaluate, for patients with ovarian cancer, the feasibility, reliability, and complications of a laparoscopic second look and to compare them with those of a second look by laparotomy. Methods, Twenty patients treated by initial surgery and adjuvant chemotherapy for ovarian carcinoma underwent a laparoscopic second look, immediately followed by a comparative laparotomy. All were in complete remission after chemotherapy, Both operations were performed according to a predefined checklist, identical for both surgical techniques and for each patient: after liberation of adhesions, an exhaustive intraperitoneal inspection was performed, with systematic peritoneal cytology and biopsies, Each patient therefore was her own control for the two techniques. Results. The positive predictive value of laparoscopy for the diagnosis of residual disease was 100% (6 of 6 cases), while the negative predictive value was 86% (2 false-negative cases out of 14). Because of the presence of postoperative adhesions, the rate of complete intraperitoneal investigation was 95% for laparotomy versus 41% for laparoscopy. The complication rate of laparoscopy requiring laparotomy was 5.3%. Conclusions. After treatment of ovarian cancer, a laparoscopic second look appears to be less reliable than one performed by laparotomy. The presence of severe postoperative adhesions is the main obstacle to an exhaustive, reliable, and safe laparoscopic second look. (C) 1999 Academic Press.
引用
收藏
页码:411 / 417
页数:7
相关论文
共 34 条
[31]   LAPAROSCOPY IN STAGING AND RESTAGING OF 95 PATIENTS WITH OVARIAN CARCINOMA [J].
SPINELLI, P ;
LUINI, A ;
PIZZETTI, P ;
PALO, GMD .
TUMORI, 1976, 62 (05) :493-501
[32]  
STOCKLE E, 1993, B CANCER, V80, P629
[33]  
VENESMAA P, 1992, OBSTET GYNECOL, V79, P168
[34]  
XYGAKIS AM, 1984, J REPROD MED, V29, P583